Lauren Lempert listened in to the presentations and scientific discussion of the RJR application to market Camel Snus as a modified (i.e., reduced) risk tobacco product on September 14, 2018. After that session, she and I prepared this public comment, wh
A scientific advisory committee of the [FDA] approved advancing the applications for six Camel Snus styles to the agency. The styles are Frost, Frost Large, Mellow, Mint, Robust and Winterchill. Snus, which became popular first in Sweden, are teabag-lik
Highlights • Any tobacco use predicted subsequent substance (alcohol or drug) use. • E-cigarette use predicted substance use except non-prescribed painkillers/sedatives. • Substance use consistently predicted tobacco use across products. • Marijuana u
Earlier this year it was announced that the U.S. Food and Drug Administration (FDA) would begin to review British American Tobacco, Plc.’s (BAT) modified risk application for Camel Snus. Camel Snus is a smokeless tobacco pouch that BAT argued was a safer alternative to traditional cigarettes [read more here]. Camel Snus is made by Reynolds […]
The post FDA Not Sold on Reynolds’ Camel Snus Modified-Risk Claims appeared first on Tobacco Business Magazine.
Submit comments including data, research, and other related information to docket FDA-2017-N-4678-0001. There is currently no deadline for public comments. There may be conflicting deadlines added on regulations.gov and federalregister.gov. While we cann
On September 14, 2018, FDA filed for substantive scientific review one Modified Risk Tobacco Product (MRTP) Application from U.S. Smokeless Tobacco Company for its Copenhagen Snuff Fine Cut, a moist snuff smokeless tobacco product.
Camel Snus/ R.J. Reynolds Tobacco Company TBD FDA-2017-N-4678 September 13-14, 2018 / FDA is making these applications available for public comment in accordance with applicable laws. FDA will post the application materials, including current and future
advanced R.J. Reynolds Tobacco Company’s efforts to communicate reduced-risk information to consumers regarding its Camel Snus products…(TPSAC) recognized that the available science supports that switching completely from cigarettes to Camel Snus can si
We highlight issues in how tobacco brand websites address youth access, display warnings, engage consumers and facilitate purchase. Results can help public health educators and practitioners better understand tobacco marketing as a context for designing t
Lauren Lempert and I just sent this letter to FDA…As of August 10, 2018, many of the most crucial Camel Snus MRTP applications materials have still not been posted for public review and comment, including: Module 6 – Summary of All Research Findings, in
Daily Sports News- Steelers have bigger problems than Brown September 18, 2018
- Week 3 Fantasy Kicker Rankings: Can you replace Greg the leg? September 18, 2018
- Waiver Wire: Week 3 September 18, 2018
- TOUR Championship Odds and Best Bets September 18, 2018
- Hue Jackson didn't know Zane Gonzalez was kicking while injured Sunday September 18, 2018
